Japanese
menu-4
close
HOME
Business Operation
skip-track2
Global Development of CHP Cancer Protein Vaccines
Drug Discovery for Multifunctional Cancer DNA Vaccines
Drug Discovery of “Therapeutics for Immune Diseases” by Exploring Immune Regulatory Mechanism
About us
News Releases
Home
2009
2009年8月
ImmunoFrontier filed an Application of CHP-NY-ESO-1 for Phase I Study with PMDA to develop for esophageal cancer.
2009/08/17
CHP-NY-ESO-1 project was chosen for NIBIO’s “Practical Application Research Supporting Program for Medicine and Medical Device”.
2009/03/10
ImmunoFrontier was reported in International Pharmaceutical Intelligence as challenging company titled “Developing vaccines and immunotherapeutic drugs based on CHP”.
2009/03/09
up-arrow-1